DIAGNOS
-
The EYES have it, Early Stage Detection of Diabetes and Cardiovascular Disease
Using Artificial Intelligence (AI) to better image and analyze the retina of the eye to detect early stage…
-
André Larente provides an update on the ‘exponential growth’ of the Diagnos AI-based telemedicine platform
In a recent InvestorIntel interview, Tracy Weslosky spoke with André Larente, President of Diagnos Inc. (TSXV: ADK |…
-
Eyes on DIAGNOS as commercialization gains momentum
The best time to buy an emerging company is when it begins commercialization. At this stage all the…
-
Diagnos’ André Larente on Entering the DACH and Central European Healthcare Market
In a recent InvestorIntel interview, Tracy Weslosky spoke with André Larente President of Diagnos Inc. (TSXV: ADK |…
-
Expanding globally in the AI image based diagnosis sector, Diagnos is actively commercializing their CARA technology
CARA’s Artificial Intelligence image enhancement algorithms make standard retinal images sharper, clearer and easier to read. CARA is…
-
Thompson on DIAGNOS and the ‘exploding’ AI healthtech industry
AI Healthcare Provider Diagnos Continues to Sign Deals and Partnerships Amid COVID-19 Crisis Diagnos Inc. (TSXV: ADK |…
-
Diagnos’ Andre Larente on the benefits of using AI for the early detection of critical health issues
“Our (AI) technology works, its in production (CARA). We are fully funded….the markets we are going after are…
-
Diagnos’ AI Platform to Fight Vision Loss Continues to Expand Globally
Diagnos Inc. (TSXV: ADK | OTCQB: DGNOF) is a software platform provider for the early detection of critical…
